Trailing-twelve-month (TTM) revenue is $15.79 Billion with a year-over-year growth of +32.80%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $3,377,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-31 |
| Q4 FY2025Period ended 2025-12-31 | $3,869,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $4,251,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $4,289,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $15,787,500,000 |
Current P/S: $166,357,398,859 market capitalization ÷ $15,787,500,000 TTM revenue = 10.54x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T15:55:06.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $4.29B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T15:56:01.524Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Copper | $6.5B | $8.8B | $7.5B | $7.6B | $8.8B | $10.0B |
| Molybdenum | $510M | $1.1B | $1.2B | $1.1B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia | $1.8B | $2.2B | $1.7B | $1.2B | $1.1B | $1.4B |
| BRAZIL | $233M | $437M | $452M | $390M |
$15.79B
$15.79 Billion
+32.80%
vs. $11.89B a year ago (TTM)
+9.76%
5 Year compound annual growth rate
1 Year
+32.80%
3 Year
+16.16%
5 Year
+9.76%
10 Year
+12.26%
15 Year
+6.47%
20 Year
+6.35%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $13.42B | +$1.99B | +17.38% |
| 2024 | $11.43B | +$1.54B | +15.54% |
| 2023 | $9.90B | ($152.10M) | (1.51%) |
| 2022 | $10.05B | ($886.20M) | (8.10%) |
| 2021 | $10.93B | +$2.95B | +36.93% |
| 2020 |
TTM Growth
+32.80%
3-Year CAGR
+16.16%
5-Year CAGR
+9.76%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T15:56:01.524Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.2B |
| $1.4B |
| Other | N/A | $289M | $540M | $456M | $410M | $477M |
|---|
| Silver | $249M | $290M | $374M | $418M | $588M | $974M |
|---|
| Zinc | $448M | $474M | $403M | $301M | $435M | $530M |
|---|
| $558M |
| CHILE | $221M | $385M | $445M | $400M | $452M | $548M |
|---|
| China | N/A | N/A | N/A | $749M | $1.2B | $1.3B |
|---|
| Europe | $2.4B | $3.2B | $2.6B | $2.4B | $3.1B | $3.6B |
|---|
| MEXICO | $1.5B | $2.1B | $2.3B | $2.7B | $2.9B | $3.3B |
|---|
| PERU | $335M | $586M | $615M | $395M | $661M | $864M |
|---|
| UNITED STATES | $1.4B | $1.9B | $1.9B | $1.7B | $1.5B | $2.0B |
|---|
| $7.98B |
| +$699.30M |
| +9.60% |
| 2019 | $7.29B | +$188.90M | +2.66% |
| 2018 | $7.10B | +$442.20M | +6.65% |
| 2017 | $6.65B | +$1.27B | +23.69% |
| 2016 | $5.38B | +$333.90M | +6.62% |
